Articles published by Merck & Co., Inc.
![](https://mms.businesswire.com/media/20230127005078/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20230126005331/en/439684/5/Merck_Animal_Health_Logo.jpg)
Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO (fluralaner) Chews for Dogs
January 26, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20230124006084/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20230125005219/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20230124005746/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Announces Second-Quarter 2023 Dividend
January 24, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20230111005341/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.
January 11, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20230110005333/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20230105005070/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck to Hold Fourth-Quarter and Full-Year 2022 Sales and Earnings Conference Call February 2
January 05, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20230103005167/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221222005094/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221222005122/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221221005090/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221215005293/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221212005250/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
December 12, 2022
From Merck & Co., Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221201005292/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221129005797/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Announces First-Quarter 2023 Dividend
November 29, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20221122005263/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221121005027/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 21, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20221121005295/en/1643500/5/Imago_Main_Logo.jpg)
![](https://mms.businesswire.com/media/20221114005261/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221107005158/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221027005289/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Announces Third-Quarter 2022 Financial Results
October 27, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20221026006036/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Robert M. Davis to Succeed Kenneth C. Frazier as Chairman of Merck
October 26, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20221024005345/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221022005008/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221018005485/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221007005569/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Recognized on Fortune’s 2022 Change the World List for Expanding Access to HPV Vaccines
October 10, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20221010005227/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221006006068/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20220929005889/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
U.S. Court of Appeals for the Federal Circuit Rules in Favor of Merck in Sitagliptin Dihydrogen Phosphate Patent Lawsuit
September 29, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.